Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

2010 Scrip 100 - Black gold and little white pills

This article was originally published in Scrip

Executive Summary

Whenever commentators discuss emerging markets in the pharmaceutical sector, the same countries usually emerge from the hat: China, India, Russia, Brazil, Mexico South Korea and Turkey. These are undoubtedly areas that have experienced significant growth over the past decade and they are likely to flourish in the future too, once they have emerged from the nadir of economic depression.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC005999

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel